Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ficocyte
- Development stage
- Unknown
- Lead developer
- Nanogen
- Modality
- Recombinant Proteins and Enzymes
- Administration
- Subcutaneous, Intravenous
01
Overview
FICOCYTE is a filgrastim biosimilar developed by Nanogen Pharmaceutical Biotechnology. It is a recombinant protein that acts as a granulocyte colony-stimulating factor (G-CSF) agonist. By binding to the G-CSF receptor (GCSFR), it stimulates the proliferation, differentiation, and activation of neutrophil precursors in the bone marrow, leading to an increase in functional neutrophil counts. FICOCYTE is indicated for the treatment and prevention of neutropenia in patients receiving myelosuppressive chemotherapy, those with chronic neutropenia, individuals with acute radiation exposure, and patients undergoing bone marrow or stem cell transplantation. It is typically administered via subcutaneous or intravenous injection.
- Brand names
- FICOCYTE
- Other names
- filgrastimG-CSFrecombinant human granulocyte colony-stimulating factor
02
Targets
CSF3R (Granulocyte colony-stimulating factor receptor)
Beyond the preview
Go deeper on ficocyte.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ficocyte.